Cargando…

Proteomic Case Studies of MDS in Progression: Heterogeneity and More Heterogeneity

Detalles Bibliográficos
Autores principales:	Pecankova, Klara, Cermak, Jaroslav, Majek, Pavel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2022
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727721/ https://www.ncbi.nlm.nih.gov/pubmed/36247531 http://dx.doi.org/10.4274/tjh.galenos.2022.2022.0290

Ejemplares similares

Posttranslational Modifications of Red Blood Cell Ghost Proteins as “Signatures” for Distinguishing between Low- and High-Risk Myelodysplastic Syndrome Patients
por: Pecankova, Klara, et al.
Publicado: (2017)

Peripheral Blood Mononuclear Cell Proteome Changes in Patients with Myelodysplastic Syndrome
por: Pecankova, Klara, et al.
Publicado: (2015)

Plasma Protein Biomarker Candidates for Myelodysplastic Syndrome Subgroups
por: Majek, Pavel, et al.
Publicado: (2015)

Proteome Changes in the Plasma of Myelodysplastic Syndrome Patients with Refractory Anemia with Excess Blasts Subtype 2
por: Majek, Pavel, et al.
Publicado: (2014)

Plasma proteome changes associated with refractory anemia and refractory anemia with ringed sideroblasts in patients with myelodysplastic syndrome
por: Májek, Pavel, et al.
Publicado: (2013)

Proteome changes of plasma-derived extracellular vesicles in patients with myelodysplastic syndrome
por: Pecankova, Klara, et al.
Publicado: (2022)

Extension of the Human Fibrinogen Database with Detailed Clinical Information—The αC-Connector Segment
por: Sovova, Zofie, et al.
Publicado: (2021)

Plasma proteome changes in cardiovascular disease patients: novel isoforms of apolipoprotein A1
por: Májek, Pavel, et al.
Publicado: (2011)

Proteome heterogeneity and malignancy detection in pancreatic cyst fluids
por: Pan, Sheng, et al.
Publicado: (2021)

Plasma proteome changes associated with refractory cytopenia with multilineage dysplasia
por: Májek, Pavel, et al.
Publicado: (2011)

Improved Coomassie Blue Dye-Based Fast Staining Protocol for Proteins Separated by SDS-PAGE
por: Májek, Pavel, et al.
Publicado: (2013)

A case of histoplasmosis in a patient with MDS/MPN-U
por: Rastogi, Pulkit, et al.
Publicado: (2016)

RUNX1 mutations contribute to the progression of MDS due to disruption of antitumor cellular defense: a study on patients with lower-risk MDS
por: Kaisrlikova, Monika, et al.
Publicado: (2022)

A case of simultaneous presentation of symptomatic PCM and MDS unrelated to prior chemotherapy
por: Kim, Hyerim, et al.
Publicado: (2015)

Heterogeneity of the Omicron variant in Senegal
por: Diédhiou, Cyrille Kouligueul, et al.
Publicado: (2022)

Heterogeneous expression of the collagen receptor DDR1 in chronic lymphocytic leukaemia and correlation with progression
por: Barisione, G, et al.
Publicado: (2017)

Prognostic value of right ventricular refractory period heterogeneity in Brugada syndrome. Independent predictor or part of something more complex?
por: Dendramis, Gregory
Publicado: (2022)

Should every Patient with MDS get Iron Chelation – Probably Yes
por: Ghosh, Kanjaksha, et al.
Publicado: (2017)

Unusual Immunophenotypic Heterogeneity in B-Lineage ALL
por: Sharma, Prashant, et al.
Publicado: (2012)

Comment on “Impact of Dose and Sensitivity Heterogeneity on TCP”
por: Grusell, Erik
Publicado: (2015)

Evaluation of DNA-Ploidy Heterogeneity in Gastric Cancers
por: Osterheld, M. C., et al.
Publicado: (2008)

NDUFAF5 variants manifest phenotypically heterogeneously
por: Finsterer, Josef
Publicado: (2018)

Prognostic value of right ventricular refractory period heterogeneity in Brugada syndrome. Independent predictor or part of something more complex? Author's reply
por: Rossi, Andrea, et al.
Publicado: (2022)

Tissue doppler echocardiography detects preclinical markers of cardiac lesion in MDS patients
por: de Castro, Cláudio César Monteiro, et al.
Publicado: (2012)

Sepsis Heterogeneity and Progression: Appraisal of Scoring System [Letter]
por: Huang, Honglian, et al.
Publicado: (2022)

Genetic heterogenicity of Angelman syndrome and its significance to the anesthesiologist
por: Gupta, Nupur, et al.
Publicado: (2015)

Phenotypic Heterogeneity of the m.14459G>A Mutation
por: Finsterer, Josef, et al.
Publicado: (2017)

Heterogeneous and Dynamic Prevalence of Asymptomatic Influenza Virus Infections
por: Leung, Nancy H.L., et al.
Publicado: (2018)

Heterogenous Immune Response to TB is Not a False Negative
por: DiNardo, Andrew
Publicado: (2020)

Plasma protein alterations in the refractory anemia with excess blasts subtype 1 subgroup of myelodysplastic syndrome
por: Májek, Pavel, et al.
Publicado: (2012)

Persistence of Long-COVID symptoms in a heterogenous prospective cohort
por: Mariani, Chiara, et al.
Publicado: (2022)

McLeod Syndrome: Report of an Indian family with phenotypic heterogeneity
por: Chakravarty, A., et al.
Publicado: (2011)

Intra-patient heterogeneity of BRAF mutation status: fact or fiction?
por: Menzies, A M, et al.
Publicado: (2014)

“Chicago Classification” Should Be Challenged in the Diagnosis of Achalasia: Heterogeneity of Achalasia
por: Lee, Tae Hee, et al.
Publicado: (2015)

Phenotypic heterogeneity of a compound heterozygous SUCLA2 mutation
por: Berry, Gerard T.
Publicado: (2017)

Olmesartan-associated enteropathy: heterogeneity of involvement along gastrointestinal tract
por: Dias, Emanuel, et al.
Publicado: (2020)

Intratumor heterogeneity of lymphoma identified by multiregion sequencing of autopsy samples
por: Makishima, Kenichi, et al.
Publicado: (2021)

On the Heterogeneity and Politics of the Judicialization of Health in Brazil
por: Biehl, João, et al.
Publicado: (2016)

Durable response of therapy-related MDS/AML with concomitant Waldenström’s macroglobulinemia treated with venetoclax and azacitidine
por: Hirano, Mitsuhito, et al.
Publicado: (2022)

Severe congenital neutropenia, a genetically heterogeneous disease group with an increased risk of AML/MDS
por: Vandenberghe, Peter, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_fegegqian7grls9di75sra25rf